期刊文献+

质子泵抑制剂研究进展 被引量:3

Progress on Research of Proton Pump Inhibitors
原文传递
导出
摘要 消化系统是人体的重要器官。也是最容易发病的器官之一。消化系统疾病是常见的多发病之一,直接或间接地影响着人类的健康。据SCRIPONLINE最新的信息,世界上40亿人患有消化系统疾病,其中以溃疡最为常见.其发病率约占人口的10%~12%。美国共有3800万人患胃肠道疾病.其中2000万患者为慢性疾病,有400万人次患消化性溃疡,主要是吸烟、饮酒、情绪紧张、药物刺激(如阿斯匹林、消炎痛等)引起的。美国发病率男性为10%.女性为5%,日本胃肠道疾病发病率为5%.10%,德国为12.3%, Gestric juice is considered to be one of the most important factor causing clinically duodenal and peptic ulceration.To reduce the secreting of gestric juice i.e.to control the pH value of the gestric juice in stomach with antisecretory drugs or surgical operation has proven to be an effective method in the treatment of duodenal and peptic ulcers.Recently,the H^+/K^+-ATP enzyme inhibitor i.e.proton pump inhibitor(PPI)which is most effective in curing ulcers so far has become a kind of new drug for inhibition of secreting of gestric juice to many researchers.The status quo,functional mechanism,development situation and research trends were summarized in this paper.
出处 《精细与专用化学品》 CAS 2008年第23期22-23,26,共3页 Fine and Specialty Chemicals
基金 北京市自然科学基金重点项目(项目批准号:2006B) 北京市教育委员会科技发展计划重点项目(项目批准号:KZ200610011006) 北京市自然科学基金项目(项目批准号:2082008)
  • 相关文献

参考文献17

  • 1[1]Edd C B,Michael A R.The mechanism and structure of the gas-tric H+/K+-ATPase[J].Annu Rev Physiol,1990,52:321~344
  • 2[2]Black J W,Duncan W,Durant C J,et al.Definition and antagonism of histamin H2-recepters[J].Nature,1972,236:385
  • 3[3]Sachs G,Carhson E,Lindberg P,et al.Gastric H+/K+-ATPase as theraspeutic target[J].Annu Rev Pharmacal Toxical,1988,28:269~284
  • 4[4]Lindberg P,Nordberg P,Alminger T,et al.The mechanism of action of the gsstric acid secretion inhibitor omerprazole[J].J Med Chem,1986,29(8):1327~1329
  • 5[5]Lindberg P.Omeprazole:the first proton pump inhibitor[J].Med Res Rev,1990,10:1~54
  • 6[6]Ife R J,Dyke C A,Keeling D J,et al.2-[((4-Amino-2-pyridyt)methyl]sulfinyl]-bensimidazole H+/K+-ATPase inhibitors,the relationship between pyridine basicity,atability and activity[J].J Med Chem,1989,32:1970~1977
  • 7[7]Suzuki M,Suzuki H,Hibi T.Proton pump inhibitors and gastritis[J].J Clin Biachem Nutr,2008,42(2):71~75
  • 8[8]Pai V,Pai N.Recent advances in chirally pure proton pump inhibitors[J].J Indian Med Assac.,2007,105(8):469~70,472,474
  • 9[9]Nakamura T.Proton pump inhibitom:tenatoprazole(TU-199)[J].Nippon Binsho,2002,60(S2):650~654
  • 10[10]Scarpignato C,Pelosini I.Review article:the opportunities and benefits of extended acid suppression[J].Aliment Pharmacol Ther,2006,23(S2):23~34

同被引文献22

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部